MedPath

modafinil in treatment of crystal dependency

Phase 2
Conditions
Amphetamine-Methamphetamine Dependency.
Mental and behavioral disorders due to use of other stimulants, dependence syndrome
Registration Number
IRCT2014090219009N1
Lead Sponsor
Zahedan University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
50
Inclusion Criteria

male gender ;eighteen to sixty five years old
;Methamphetamine dependency approved by DMSIV-TR criteria
; Positive urine test for amphetamine and methamphetamine
; Having no contraindication for the use of modafinil
Exclusion criteria:
consuming different kind of drugs except for nicotine and methadone
; No history of psychiatric disorders
; Having medical conditions that may interfere with using modafinil
; Having suicidal thoughts and aggression
;. Participating in another study simultaneously
; Quitting the current study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measure of craving. Timepoint: At the onset of the study and then weekly. Method of measurement: visual analogue of craving score.;Measuring the severity of dependency. Timepoint: At the onset of the study and then weeks 6th and 12th. Method of measurement: Dependency severity index.;Measuring the severity of depression. Timepoint: At the onset of the study and then weeks 6th and 12th. Method of measurement: Beck’s Depression Inventory.;Measuring the aggression severity. Timepoint: At the onset of the study and then weeks 6th and 12th. Method of measurement: Aggressive questionnaire (AGQ).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath